Access
To read this story in full you will need to login or make a payment (see right).
Outlook
Nature 430, 942-943 (19 August 2004) | doi:10.1038/430942a; Published online 18 August 2004
Open Innovation Challenges
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
- More Challenges
- Powered by:
nature jobs
University Full-Professor (W3, Tenure Track)
- University of Münster
- Munster 48149 Germany
Account Director -India
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Malaria Winning the drugs war
Abstract
We have the science to make new antimalarials, say Robert Ridley and Yeya Toure, but we need better mechanisms and resources to develop drugs and deliver them.
In the 1990s, prospects for antimalarial chemotherapy became increasingly bleak owing to growing parasite resistance to chloroquine and sulphadoxine-pyrimethamine. Artemisinin-based drugs showed great promise in southeast Asia, but were barely used in Africa because of their cost and a lack of clinical data.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
New agents to combat malariaNature Medicine News and Views (01 Feb 2001)
Malaria To kill a parasiteNature News and Views (21 Aug 2003)
